GlassScriptPhysician profile
Iram Mall
NPI 1538573514
$7,289.51
in general payments reported to CMS, 2019-2025
36 companies · $1,539 in 2025
The $1,539 reported for 2025 was more than what 92% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $483 · 2020: $422 · 2021: $808 · 2022: $1,572 · 2023: $1,007 · 2024: $1,459 · 2025: $1,539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,955 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,955.27 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,228.36 | 2021-2025 | |
| Glaxosmithkline, LLC. | $924.08 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $795.39 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $697.86 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $520.15 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $331.43 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $296.34 | 2019-2024 | Jardiance |
| Amgen INC. | $239.26 | 2019-2025 | Otezla, Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $237.41 | 2022-2024 | Xarelto, Spravato |
| Novartis Pharmaceuticals Corporation | $224.17 | 2019-2025 | |
| Abbott Laboratories | $194.52 | 2022-2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $152.01 | 2019-2023 | Verquvo, Belsomra |
| Biohaven Pharmaceutical Holding Company LTD. | $143.91 | 2022 | |
| Exact Sciences Corporation | $141.31 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Nestle Healthcare Nutrition INC. | $121.84 | 2022-2023 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Iram Mall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.